Top Stories

EMA official says AstraZeneca shots have good risk-benefit profile for over 60s

Published by Wanda Rich

Posted on June 14, 2021

· Last updated: January 21, 2026

Add as preferred source on Google
AstraZeneca COVID-19 vaccine syringe with EMA official statement on risk-benefit profile for seniors - Global Banking & Finance Review
This image features a syringe filled with the AstraZeneca COVID-19 vaccine, highlighting the EMA's endorsement of its risk-benefit profile for individuals over 60. It underscores the ongoing discussions in the healthcare community regarding vaccination strategies for older adults.
Global Banking & Finance Awards 2026 — Call for Entries

Related Articles

More from Top Stories

Explore more articles in the Top Stories category